{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:36:35Z","timestamp":1790361395874,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["Grants-in-Aid for Scientific Research (B)"],"award-info":[{"award-number":["Grants-in-Aid for Scientific Research (B)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["No. 16H05039"],"award-info":[{"award-number":["No. 16H05039"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2019","award":["Kitasato University Research Grant for Young Researchers"],"award-info":[{"award-number":["Kitasato University Research Grant for Young Researchers"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00705-020-04605-7","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T16:03:47Z","timestamp":1585670627000},"page":"1197-1206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic effect of an anti-human-TNF-alpha antibody and itraconazole on feline infectious peritonitis"],"prefix":"10.1007","volume":"165","author":[{"given":"Tomoyoshi","family":"Doki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hohdatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"4605_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","volume":"201","author":"NC Pedersen","year":"2014","unstructured":"Pedersen NC (2014) An update on feline infectious peritonitis: diagnostics and therapeutics. Vet J 201:133\u2013141. https:\/\/doi.org\/10.1016\/j.tvjl.2014.04.016","journal-title":"Vet J"},{"key":"4605_CR2","doi-asserted-by":"crossref","unstructured":"Tekes G, Thiel HJ (2016) Feline coronaviruses: pathogenesis of feline infectious peritonitis. In: Ziebuhr J (ed) Advances in virus research, vol. 96, Academic Press, pp 193\u2013218","DOI":"10.1016\/bs.aivir.2016.08.002"},{"key":"4605_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.virol.2017.12.027","volume":"517","author":"JA Jaimes","year":"2018","unstructured":"Jaimes JA, Whittaker GR (2018) Feline coronavirus: insights into viral pathogenesis based on the spike protein structure and function. Virology 517:108\u2013121. https:\/\/doi.org\/10.1016\/j.virol.2017.12.027","journal-title":"Virology"},{"key":"4605_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1128\/jvi.01937-08","volume":"83","author":"N Decaro","year":"2009","unstructured":"Decaro N, Mari V, Campolo M et al (2009) Recombinant canine coronaviruses related to transmissible gastroenteritis virus of swine are circulating in dogs. J Virol 83:1532\u20131537. https:\/\/doi.org\/10.1128\/jvi.01937-08","journal-title":"J Virol"},{"key":"4605_CR5","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1128\/JVI.72.5.4508-4514.1998","volume":"72","author":"AA Herrewegh","year":"1998","unstructured":"Herrewegh AA, Smeenk I, Horzinek MC et al (1998) Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 72:4508\u20134514","journal-title":"J Virol"},{"key":"4605_CR6","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1099\/vir.0.043992-0","volume":"93","author":"Y Terada","year":"2012","unstructured":"Terada Y, Shiozaki Y, Shimoda H et al (2012) Feline infectious peritonitis virus with a large deletion in the 59-terminal region of the spike gene retains its virulence for cats. J Gen Virol 93:1930\u20131934. https:\/\/doi.org\/10.1099\/vir.0.043992-0","journal-title":"J Gen Virol"},{"key":"4605_CR7","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1099\/vir.0.19129-0","volume":"84","author":"DD Addie","year":"2003","unstructured":"Addie DD, Schaap IAT, Nicolson L, Jarrett O (2003) Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol 84:2735\u20132744. https:\/\/doi.org\/10.1099\/vir.0.19129-0","journal-title":"J Gen Virol"},{"key":"4605_CR8","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1128\/CDLI.12.10.1209-1215.2005","volume":"12","author":"M Kummrow","year":"2005","unstructured":"Kummrow M, Meli ML, Haessig M et al (2005) Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol 12:1209\u20131215. https:\/\/doi.org\/10.1128\/CDLI.12.10.1209-1215.2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"4605_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1292\/jvms.54.557","volume":"54","author":"T Hohdatsu","year":"1992","unstructured":"Hohdatsu T, Okada S, Ishizuka Y et al (1992) The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci 54:557\u2013562. https:\/\/doi.org\/10.1292\/jvms.54.557","journal-title":"J Vet Med Sci"},{"key":"4605_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.vetmic.2006.08.033","volume":"119","author":"T Takano","year":"2007","unstructured":"Takano T, Hohdatsu T, Hashida Y et al (2007) A \u201cpossible\u201d involvement of TNF-alpha in apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis. Vet Microbiol 119:121\u2013131. https:\/\/doi.org\/10.1016\/j.vetmic.2006.08.033","journal-title":"Vet Microbiol"},{"key":"4605_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2007.02.006","volume":"364","author":"T Takano","year":"2007","unstructured":"Takano T, Hohdatsu T, Toda A et al (2007) TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology 364:64\u201372. https:\/\/doi.org\/10.1016\/j.virol.2007.02.006","journal-title":"Virology"},{"key":"4605_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00705-009-0371-3","volume":"154","author":"T Takano","year":"2009","unstructured":"Takano T, Azuma N, Satoh M et al (2009) Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the pathogenesis of granulomatous lesions. Arch Virol 154:775\u2013781. https:\/\/doi.org\/10.1007\/s00705-009-0371-3","journal-title":"Arch Virol"},{"key":"4605_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.rvsc.2013.09.005","volume":"95","author":"T Doki","year":"2013","unstructured":"Doki T, Takano T, Nishiyama Y et al (2013) Generation, characterization and therapeutic potential of anti-feline TNF-alpha MAbs for feline infectious peritonitis. Res Vet Sci 95:1248\u20131254. https:\/\/doi.org\/10.1016\/j.rvsc.2013.09.005","journal-title":"Res Vet Sci"},{"key":"4605_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.rvsc.2015.11.005","volume":"104","author":"T Doki","year":"2016","unstructured":"Doki T, Takano T, Kawagoe K et al (2016) Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis. Res Vet Sci 104:17\u201323. https:\/\/doi.org\/10.1016\/j.rvsc.2015.11.005","journal-title":"Res Vet Sci"},{"key":"4605_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH et al (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117:244\u2013279","journal-title":"Pharmacol Ther"},{"key":"4605_CR16","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/JVI.01348-12","volume":"86","author":"Y Kim","year":"2012","unstructured":"Kim Y, Lovell S, Tiew K-C et al (2012) Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol 86:11754\u201311762. https:\/\/doi.org\/10.1128\/JVI.01348-12","journal-title":"J Virol"},{"key":"4605_CR17","doi-asserted-by":"publisher","first-page":"e1005531","DOI":"10.1371\/journal.ppat.1005531","volume":"12","author":"Y Kim","year":"2016","unstructured":"Kim Y, Liu H, Galasiti Kankanamalage AC et al (2016) Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor. PLoS Pathog 12:e1005531. https:\/\/doi.org\/10.1371\/journal.ppat.1005531","journal-title":"PLoS Pathog"},{"key":"4605_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","volume":"219","author":"BG Murphy","year":"2018","unstructured":"Murphy BG, Perron M, Murakami E et al (2018) The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol 219:226\u2013233. https:\/\/doi.org\/10.1016\/j.vetmic.2018.04.026","journal-title":"Vet Microbiol"},{"key":"4605_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1098612X17729626","volume":"20","author":"NC Pedersen","year":"2018","unstructured":"Pedersen NC, Kim Y, Liu H et al (2018) Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J Feline Med Surg 20:378\u2013392. https:\/\/doi.org\/10.1177\/1098612X17729626","journal-title":"J Feline Med Surg"},{"key":"4605_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1098612X19825701","volume":"21","author":"NC Pedersen","year":"2019","unstructured":"Pedersen NC, Perron M, Bannasch M et al (2019) Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg 21:271\u2013281. https:\/\/doi.org\/10.1177\/1098612X19825701","journal-title":"J Feline Med Surg"},{"key":"4605_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13567-019-0625-3","volume":"50","author":"T Takano","year":"2019","unstructured":"Takano T, Akiyama M, Doki T, Hohdatsu T (2019) Antiviral activity of itraconazole against type I feline coronavirus infection. Vet Res 50:5. https:\/\/doi.org\/10.1186\/s13567-019-0625-3","journal-title":"Vet Res"},{"key":"4605_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.antiviral.2017.07.022","volume":"145","author":"T Takano","year":"2017","unstructured":"Takano T, Endoh M, Fukatsu H et al (2017) The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection. Antivir Res 145:96\u2013102. https:\/\/doi.org\/10.1016\/j.antiviral.2017.07.022","journal-title":"Antivir Res"},{"key":"4605_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/pathogens8040300","volume":"8","author":"T Takano","year":"2019","unstructured":"Takano T, Wakayama Y, Doki T (2019) Endocytic pathway of feline coronavirus for cell entry: differences in serotype-dependent viral entry pathway. Pathogens 8:300. https:\/\/doi.org\/10.3390\/pathogens8040300","journal-title":"Pathogens"},{"key":"4605_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1292\/jvms.64.453","volume":"64","author":"L Koga","year":"2002","unstructured":"Koga L, Kobayashi Y, Yazawa M et al (2002) Nucleotide sequence and expression of the feline vascular endothelial growth factor. J Vet Med Sci 64:453\u2013456. https:\/\/doi.org\/10.1292\/jvms.64.453","journal-title":"J Vet Med Sci"},{"key":"4605_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/mcpr.2002.0405","volume":"16","author":"S Fronhoffs","year":"2002","unstructured":"Fronhoffs S, Totzke G, Stier S et al (2002) A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes 16:99\u2013110. https:\/\/doi.org\/10.1006\/mcpr.2002.0405","journal-title":"Mol Cell Probes"},{"key":"4605_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1051\/vetres:2002064","volume":"34","author":"A Aguirre","year":"2003","unstructured":"Aguirre A, Escobar A, Ferreira V et al (2003) An anti-human recombinant tumor necrosis factor alpha (TNF\u03b1) monoclonal antibody recognizes an epitope in feline TNF\u03b1. Vet Res 34:177\u2013184. https:\/\/doi.org\/10.1051\/vetres:2002064","journal-title":"Vet Res"},{"key":"4605_CR27","doi-asserted-by":"publisher","first-page":"27059","DOI":"10.1074\/jbc.M113.491530","volume":"288","author":"S Hu","year":"2013","unstructured":"Hu S, Liang S, Guo H et al (2013) Comparison of the inhibition mechanisms of Adalimumab and Infliximab in treating tumor necrosis factor \u03b1-associated diseases from a molecular view. J Biol Chem 288:27059\u201327067. https:\/\/doi.org\/10.1074\/jbc.M113.491530","journal-title":"J Biol Chem"},{"key":"4605_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.virusres.2011.03.027","volume":"158","author":"T Takano","year":"2011","unstructured":"Takano T, Ohyama T, Kokumoto A et al (2011) Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP. Virus Res 158:161\u2013168. https:\/\/doi.org\/10.1016\/j.virusres.2011.03.027","journal-title":"Virus Res"},{"key":"4605_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1365-2125.1999.00095.x","volume":"48","author":"LA Garc\u00eda Rodr\u01d0guez","year":"1999","unstructured":"Garc\u00eda Rodr\u01d0guez LA, Duque A, Castellsague J et al (1999) A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol 48:847\u2013852. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00095.x","journal-title":"Br J Clin Pharmacol"},{"key":"4605_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/bcp.12178","volume":"77","author":"WY Kao","year":"2014","unstructured":"Kao WY, Su CW, Huang YS et al (2014) Risk of oral antifungal agent-induced liver injury in Taiwanese. Br J Clin Pharmacol 77:180\u2013189. https:\/\/doi.org\/10.1111\/bcp.12178","journal-title":"Br J Clin Pharmacol"},{"key":"4605_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2165\/00003495-198937030-00003","volume":"37","author":"M Susan","year":"1989","unstructured":"Susan M, Grant SPC (1989) Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 37:310\u2013344","journal-title":"Drugs"},{"key":"4605_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6746989","author":"S Khoza","year":"2017","unstructured":"Khoza S, Moyo I, Ncube D (2017) Comparative hepatotoxicity of fluconazole, ketoconazole, itraconazole, terbinafine, and griseofulvin in rats. J Toxicol. https:\/\/doi.org\/10.1155\/2017\/6746989","journal-title":"J Toxicol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04605-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-020-04605-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04605-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:25:41Z","timestamp":1744151141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-020-04605-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4605"],"URL":"https:\/\/doi.org\/10.1007\/s00705-020-04605-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"30 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable national and institutional guidelines for the care and use of animals were followed. The animal experimentation protocol was approved by the President of Kitasato University through the judgment of the Institutional Animal Care and Use Committee of Kitasato University (approval no. 18-152). The SPF cats were bred in our own laboratory and maintained in a temperature-controlled isolated facility. Sample sizes were determined based on our experience with FIPV infection models, and the minimum number of cats was used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the legal custodian of all experimental animals described in this work for the procedures undertaken. No animals or humans are identifiable within this publication, and therefore additional informed consent for publication was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}